Pfizer and Flagship Pioneering have settled on the first target for their billion-dollar, multiprogram collaboration, and it’s not exactly a surprise:
The New York Big Pharma giant will work with the venture creation firm’s ProFound Therapeutics to DEVELOP NEW OBESITY DRUGS.
No financial details of the collaboration were released. However, previously the companies committed $50 million each for the opportunity to develop 10 programs. Each successful drug from the partnership could be worth as much as $700 million in various milestones and payments.
From Pandemics to Epidemics you can rely on Pfizer to come up with the goods.
We all know obesity is an epidemic coz that's what MSN tells us.
So for all you fatties out there that don't know the difference between an apple and a toffee apple then Pfizer are spending millions to help you.
